Advancements in AI-driven diagnostics could transform cardiology, enabling autonomous interpretation of up to 80% of cardiac imaging within a decade. David Ouyang, MD, discusses overcoming barriers to running…
John S. Ikonomidis, MD, PhD, Associate Professor, Cardiothoracic Surgery, Medical University of South Carolina, discusses the use of cardiac assist devices. References and Resources Pitsis AA, Kelpis TG,…
The FDA has approved regadenoson (Lexiscan) injection for patients unable to exercise sufficiently for a coronary stress test. fda.gov Sponsored by The Doctor’s Channel
The following is a video compilation summarizing the latest medical breakthroughs from the American College of Cardiology – 57th Annual Scientific Session. For more information visit: American College…
Parker Ward, MD, Associate Professor of Medicine, Director Cardiovascular Fellowship Program, University of Chicago Hospital, discusses the COURAGE trial. References and Resources Boden W, O’Rourke R, Teo K…
The American Heart Association has issued consensus guidelines for treating resistant hypertension. References and Resources Calhoun DA, et al. Resistant hypertension: Diagnosis, evaluation, and treatment. A scientific statement…
Reversal of coronary stenosis seen by intravascular ultrasound after two years of rosuvastatin (Crestor) treatment has been confirmed in the same patients by quantitative coronary angiograpy. References and…
The investigational antiplatelet agent Prasugrel improves ischemic event rates after percutaneous coronary intervention, whatever type of stent is used, researchers reported at the American College of Cardiology meeting.…
New data stemming from the PERISCOPE trial show intravascular ultrasound (IVUS) technology found that in patients living with type 2 diabetes, Actos reduced the atherosclerotic burden in the…
According to the FDA, mortality was substantially higher in patients who had an AneuRx Stent Graft implanted to prevent abdominal aortic aneurysm rupture than in patients who had…
The FDA has posted a warning alerting clinicians of pooled data from 29 placebo-controlled trials of tiotropium that revealed excess strokes among COPD patients on active treatment. References…
